Latest Investigation News

Odessa Minerals has reported encouraging exploration results at its WA projects, confirming potential carbonatite-hosted rare earth elements and new base metal anomalies, while securing $2.65 million in fresh capital to fund a maiden 10,000m drilling campaign and project acquisitions.

NOVONIX has hit a critical milestone by delivering a synthetic graphite anode sample to Panasonic, supporting a planned production start in late 2027. The company secured A$21.66 million in fresh capital to fund production readiness, while navigating an evolving US trade and policy landscape aimed at boosting domestic battery materials.

True North Copper (ASX:TNC) reported strong progress in Q4 FY2026, expanding its Mt Oxide copper system and consolidating its Cloncurry assets ahead of a key Pre-Feasibility Study.

Fortuna Metals has declared a maiden mineral resource at its Mkanda project in Malawi, ranking it among the top six rutile deposits worldwide, while locking in a strategic US investment of A$8.6 million from WNDR to boost market exposure.

Lunnon Metals boosts cash to $22.2 million as Lady Herial mining wraps up, launching a record $13 million exploration budget targeting up to 2.4 million ounces of gold at Foster-Baker.

Vital Metals has confirmed and expanded rare earth and niobium mineralisation at its Tardiff deposit in Canada, with high-grade drill results pushing beyond the existing resource envelope. Anomalous gallium values also emerged, prompting further study.

AdAlta has completed a key US$1 million milestone payment securing rights to its lead CAR-T therapy EW-001 outside Greater China, progressed Australian manufacturing with first runs expected late 2026, and is preparing for a critical pre-IND meeting with the US FDA.

Artrya is advancing its commercial footprint in the US with two health systems now generating revenue and FDA clearance for its Salix Coronary Flow module expected in H2 2026.

Amplia Therapeutics reported encouraging mature data from its ACCENT trial, initiated a Phase 2b pancreatic cancer study, launched an ovarian cancer trial, and refreshed its board leadership while maintaining a solid cash balance of A$24 million.

OD6 Metals has revealed gold assays up to 6.31g/t at its Quinn Fluorspar Project in Nevada, highlighting a large epithermal mineral system with potential for both epithermal and Carlin-style gold deposits alongside its core fluorspar targets.

LE Minerals has received further assay results from its Burke-Mt Dromedary drilling program, confirming thick, high-grade graphite mineralisation between deposits and supporting an expanded resource estimate. The company is advancing a $20 million sale of these assets to M Battery Materials, which plans an ASX IPO.

PC Gold significantly boosted its Spring Hill gold resource by 84% to 1.51 million ounces, unveiling new mineralised zones and advancing its Pre-Feasibility Study, while securing strategic acquisitions to support development.